Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
This week I briefly look at:Ā Avic International Holdings Ltd (161 HK), again, as investors take-profit while 69.7%-held subsidiaryĀ Shennan Circuits...